Analytical Data
-
基因名
lpqE
- Application
-
别名
/
-
种属
Mycobacterium tuberculosis
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P9WK62
-
表达区间
30-182aa
-
分子量
23.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the lpqE recombinant protein is rooted in its significance within the context of infectious diseases, particularly in relation to Mycobacterium tuberculosis (M. tuberculosis), the causative agent of tuberculosis (TB). LpqE, a lipid-binding protein, plays a crucial role in the pathogenesis of M. tuberculosis by participating in the interaction between the bacterium and the host's immune system. Understanding the functions and mechanisms of lpqE is essential for unraveling the complex host-pathogen interactions that occur during TB infection. Additionally, lpqE's potential as a vaccine candidate and its relevance in the development of novel therapeutic strategies highlight the importance of this protein in the broader scope of tuberculosis research. Recent advances in recombinant DNA technology have facilitated the production and characterization of lpqE, allowing researchers to explore its structural properties and immunogenicity. Investigating lpqE not only enhances our comprehension of M. tuberculosis biology but also assists in identifying new targets for drug development and vaccine formulation, contributing to the global effort to combat tuberculosis, a disease that remains a major public health challenge worldwide. Thus, the ongoing research into the lpqE recombinant protein is pivotal in addressing the persistent threat of TB and improving the efficacy of intervention strategies.
